N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA
The presence of N-nitrosamines - potentially carcinogenic compounds - is being reported for more than 50 years in pharmaceutical products. However, it only gained notorious prominence in 2018, when regulatory agencies became aware of the presence of N-nitrosodimethylamine in angiotensin II receptor antagonists, drugs that are known as sartans. It did not take long for N-nitrosamine impurities to be identified in other medicines, alerting government agencies and pharmaceutical industries to evaluate and control these impurities in their products to mitigate the risk. The sources of contamination can be numerous, including the use of contaminated raw material, formation in the synthesis of active pharmaceutical ingredients or during storage, the water used in the process, and the packaging material. This review article presents the timeline of the presence of N-nitrosamines in consuming products, toxicological aspects, legislation, and analytical methods. It provides relevant information on possible sources of contamination in the production and storage process that may explain the presence of these compounds considered a cohort of concern in pharmaceuticals.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | Portuguese |
Published: |
Sociedade Brasileira de Química
2022
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422022000800959 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0100-40422022000800959 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0100-404220220008009592022-10-24N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGAAglio,Tharcilla de CastroDiniz,VinicíusMatos,Maria Fernanda Araujo VieiraRosa,Paulo Pires CesarRath,Susanne N-nitrosamines pharmaceuticals nitrosating agents nitrosable amines DNA reactive impurities. The presence of N-nitrosamines - potentially carcinogenic compounds - is being reported for more than 50 years in pharmaceutical products. However, it only gained notorious prominence in 2018, when regulatory agencies became aware of the presence of N-nitrosodimethylamine in angiotensin II receptor antagonists, drugs that are known as sartans. It did not take long for N-nitrosamine impurities to be identified in other medicines, alerting government agencies and pharmaceutical industries to evaluate and control these impurities in their products to mitigate the risk. The sources of contamination can be numerous, including the use of contaminated raw material, formation in the synthesis of active pharmaceutical ingredients or during storage, the water used in the process, and the packaging material. This review article presents the timeline of the presence of N-nitrosamines in consuming products, toxicological aspects, legislation, and analytical methods. It provides relevant information on possible sources of contamination in the production and storage process that may explain the presence of these compounds considered a cohort of concern in pharmaceuticals.info:eu-repo/semantics/openAccessSociedade Brasileira de QuímicaQuímica Nova v.45 n.8 20222022-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422022000800959pt10.21577/0100-4042.20170894 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
Portuguese |
format |
Digital |
author |
Aglio,Tharcilla de Castro Diniz,Vinicíus Matos,Maria Fernanda Araujo Vieira Rosa,Paulo Pires Cesar Rath,Susanne |
spellingShingle |
Aglio,Tharcilla de Castro Diniz,Vinicíus Matos,Maria Fernanda Araujo Vieira Rosa,Paulo Pires Cesar Rath,Susanne N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
author_facet |
Aglio,Tharcilla de Castro Diniz,Vinicíus Matos,Maria Fernanda Araujo Vieira Rosa,Paulo Pires Cesar Rath,Susanne |
author_sort |
Aglio,Tharcilla de Castro |
title |
N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
title_short |
N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
title_full |
N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
title_fullStr |
N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
title_full_unstemmed |
N-NITROSAMINAS EM MEDICAMENTOS: UM PROBLEMA ATUAL, UMA REALIDADE ANTIGA |
title_sort |
n-nitrosaminas em medicamentos: um problema atual, uma realidade antiga |
description |
The presence of N-nitrosamines - potentially carcinogenic compounds - is being reported for more than 50 years in pharmaceutical products. However, it only gained notorious prominence in 2018, when regulatory agencies became aware of the presence of N-nitrosodimethylamine in angiotensin II receptor antagonists, drugs that are known as sartans. It did not take long for N-nitrosamine impurities to be identified in other medicines, alerting government agencies and pharmaceutical industries to evaluate and control these impurities in their products to mitigate the risk. The sources of contamination can be numerous, including the use of contaminated raw material, formation in the synthesis of active pharmaceutical ingredients or during storage, the water used in the process, and the packaging material. This review article presents the timeline of the presence of N-nitrosamines in consuming products, toxicological aspects, legislation, and analytical methods. It provides relevant information on possible sources of contamination in the production and storage process that may explain the presence of these compounds considered a cohort of concern in pharmaceuticals. |
publisher |
Sociedade Brasileira de Química |
publishDate |
2022 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422022000800959 |
work_keys_str_mv |
AT agliotharcilladecastro nnitrosaminasemmedicamentosumproblemaatualumarealidadeantiga AT dinizvinicius nnitrosaminasemmedicamentosumproblemaatualumarealidadeantiga AT matosmariafernandaaraujovieira nnitrosaminasemmedicamentosumproblemaatualumarealidadeantiga AT rosapaulopirescesar nnitrosaminasemmedicamentosumproblemaatualumarealidadeantiga AT rathsusanne nnitrosaminasemmedicamentosumproblemaatualumarealidadeantiga |
_version_ |
1756387771167014912 |